{
    "nct_id": "NCT04978675",
    "official_title": "A Prospective Pilot Study Investigating rhPSMA 7.3 PET/MRI in Detecting Recurrent Disease and Aid in Radiotherapy Planning in Patients With Biochemically Recurrent Prostate Cancer",
    "inclusion_criteria": "* Patient is male and aged > 18 years old\n* History of localized adenocarcinoma of the prostate status post (s/p) radical prostatectomy\n* An initial elevated PSA >= 0.2 followed by a subsequent confirmatory PSA >= 0.2 clinically suspicious for biochemically recurrent disease\n* If the patients were previously taking androgen deprivation therapy (ADT), it should be discontinued at least 12 weeks prior to the study\n* Treatment plan includes salvage radiation with or without hormones.\n* Patient willing to provide signed informed consent and willing to comply with all required study schedule events, where safe and feasible\n* Non-English speaking patients may be enrolled.\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Patients with any medical condition or circumstance that the investigator believes may compromise the data collected or lead to a failure to fulfil the study requirements\n* Patients who are planned to have an Iodinated contrast agent with computed tomography (CT) or gadolinium based contrast agent with MRI or other PET radiotracer < 24 hours prior to the PET scan\n* Patients with contraindication to undergo MRI\n* Patients with extreme claustrophobia\n* Patients with prior allergy to MRI contrast agent\n* Patients who are cognitively impaired",
    "miscellaneous_criteria": ""
}